Status:
RECRUITING
Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
RAND
Conditions:
Multiple Chronic Conditions
Adverse Event
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to predict and minimize post-discharge adverse events (AEs) during care transitions through early identification and escalation of patient-reported symptoms to inpatient and ambulatory...
Detailed Description
Adverse events (AE) during care transitions range from 19-28% and may lead to readmissions, representing an ongoing threat to patient safety. Early identification and escalation of patient-reported sy...
Eligibility Criteria
Inclusion
- Adult (18 years or older)
- Hospitalized on the general medicine services at Brigham and Women's Hospital or Brigham and Women's Faulkner Hospital for at least 24 hours
- Have a discharge status of home, home with services, or facility
- English-speaking patients or their English-speaking legally designated healthcare proxy or next of kin (i.e., a family caregiver)
- Non-English-speaking patients who have an English-speaking legally designated healthcare proxy or next of kin (i.e., a family caregiver)
- Two or more chronic conditions: Anxiety, Asthma\*, Arthritis (Osteoarthritis, Rheumatoid), Atrial Fibrillation, Cancer\*, Cerebral vascular accident, Chronic kidney disease\*, Chronic obstructive pulmonary disease (COPD)\*, Cirrhosis, Coronary artery disease/Ischemic heart disease, Dementia, Depression, Diabetes mellitus\*, End-stage renal disease\*, Heart failure\*, Hepatitis B, C\*, HIV/AIDs, Hyperlipidemia, Hypertension, Inflammatory bowel disease, Osteoporosis, Sickle cell disease, Substance abuse (Alcohol/Opioid)
Exclusion
- Less than 18 years of age
- Less than two chronic conditions
- Hospitalized less than 24 hours
- No identifiable healthcare proxy or next of kin (i.e., a family caregiver)
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 15 2026
Estimated Enrollment :
1300 Patients enrolled
Trial Details
Trial ID
NCT05282654
Start Date
February 1 2022
End Date
October 15 2026
Last Update
December 7 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Faulkner Hospital
Boston, Massachusetts, United States, 02115
2
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115